Results 221 to 230 of about 26,425 (258)

Anti-IgE Qb-VLP Conjugate Vaccine Self-Adjuvants Through Activation of TLR7

Vaccines, 2016
Michael J McCluskie, Bassel Akache, Brian Champion   +2 more
exaly  

Triple Layered Rotavirus VLP Production: Kinetics of Vector Replication, mRNA Stability and Recombinant Protein Production

Journal of Biotechnology, 2005
Helena L. Vieira, Cristina Peixoto, Pedro Cruz   +2 more
exaly  

A Hybrid VLP and VLC System Using m-CAP Modulation and Fingerprinting Algorithm

Optics Communications, 2020
Zabih Ghassemlooy, Gholamreza Baghersalimi   +1 more
exaly  

Characterization of the HPV-Specific Memory B Cell and Systemic Antibody Responses in Women Receiving an Unadjuvanted HPV16 L1 VLP Vaccine

Vaccine, 2010
Allan Hildesheim, Yuanji Pan
exaly  

RETARGETING OF VIRUSES OR VLPs

2018
GRUBER JENS, SCHNEIDER STEFAN, ECKERMANN-FELKL ELLEN, MOSBLECH ALINA, STEUERNAGEL ARND, WEGENER DENNIS, PLAGA JULIAN   +6 more
openaire   +3 more sources

DNA–VLP Prime–Boost Intra-Nasal Immunization Induces Cellular and Humoral Anti-HIV-1 Systemic and Mucosal Immunity With Cross-Clade Neutralizing Activity

Vaccine, 2007
Maria Lina Tornesello, Luigi Buonaguro, Franco M Buonaguro   +2 more
exaly  

Structural Insight Into CVB3-VLP Non-Adjuvanted Vaccine

Microorganisms, 2020
Niila Jouppila, Amir-Babak Sioofy-Khojine, Minna M Hankaniemi   +2 more
exaly  

In Vitro Stimulation of Human Influenza-Specific CD8+ T Cells by Dendritic Cells Pulsed With an Influenza Virus-Like Particle (VLP) Vaccine

Vaccine, 2010
Haifeng Song
exaly  

Biophysical Characterization of VLPs

Genetic Engineering & Biotechnology News, 2015
openaire   +1 more source

Combined Prophylactic and Therapeutic Cancer Vaccine: Enhancing CTL Responses to HPV16 E2 Using a Chimeric VLP in HLA-A2 Mice

International Journal of Cancer, 2006
John T. Schiller, Jay A Berzofsky, Samir N Khleif   +2 more
exaly